Invasive breast carcinoma - IARC

1262. Hughesdon PE (1982). Ovarian
tumours of Wolffian or allied nature: their
place in ovarian oncology. J Clin Pathol 35:
526-535.
1263. Hugues FC, Gourlot C, Le Jeunne C
(2000). [Drug-induced gynecomastia]. Ann
Med Interne (Paris) 151: 10-17.
1264. Hull MT, Warfel KA (1986). Glycogenrich
clear cell carcinomas of the breast. A
clinicopathologic and ultrastructural
study. Am J Surg Pathol 10: 553-559.
1265. Hull MT, Warfel KA (1987). Mucinous
breast carcinomas with abundant intracytoplasmic
mucin and neuroendocrine features:
light microscopic, immunohistochemical,
and ultrastructural study.
Ultrastruct Pathol 11: 29-38.
1266. Humeniuk V, Forrest AP, Hawkins RA,
Prescott R (1983). Elastosis and primary
breast cancer. Cancer 52: 1448-1452.
1267. Hunt CR, Hale RJ, Armstrong C,
Rajkumar T, Gullick WJ, Buckley CH (1995).
c-erbB-3 proto-oncogene expression in
uterine cervical carcinoma. Int J Gynecol
Cancer 5: 282-285.
1268. Hunt SJ, Santa Cruz DJ, Barr RJ
(1990). Cellular angiolipoma. Am J Surg
Pathol 14: 75-81.
1269. Hunter CE Jr., Sawyers JL (1980).
Intracystic papillary carcinoma of the
breast. South Med J 73: 1484-1486.
1270. Huntington RW Jr., Bullock WK
(1970). Yolk sac tumors of extragonadal origin.
Cancer 25: 1368-1376.
1271. Huntsman DG, Clement PB, Gilks CB,
Scully RE (1994). Small-cell carcinoma of
the endometrium. A clinicopathological
study of sixteen cases. Am J Surg Pathol
18: 364-375.
1272. Husseinzadeh N, Recinto C (1999).
Frequency of invasive cancer in surgically
excised vulvar lesions with intraepithelial
neoplasia (VIN 3). Gynecol Oncol 73: 119-
120.
1273. Huvos AG, Lucas JC Jr., Foote FW Jr.
(1973). Metaplastic breast carcinoma. Rare
form of mammary cancer. N Y State J Med
73: 1078-1082.
1274. Iacocca MV, Maia DM (2001).
Bilateral infiltrating lobular carcinoma of
the breast with osteoclast-like giant cells.
Breast J 7: 60-65.
1275. Ibrahim RE, Sciotto CG, Weidner N
(1989). Pseudoangiomatous hyperplasia of
mammary stroma. Some observations
regarding its clinicopathologic spectrum.
Cancer 63: 1154-1160.
1275a. Ichihara S, Aoyama H (1994).
Intraductal carcinoma of the breast arising in
sclerosing adenosis. Pathol Int 44: 722-726.
1276. Ichikawa Y, Lemon SJ, Wang S,
Franklin B, Watson P, Knezetic JA, Bewtra
C, Lynch HT (1999). Microsatellite instability
and expression of MLH1 and MSH2 in
normal and malignant endometrial and
ovarian epithelium in hereditary nonpolyposis
colorectal cancer family members.
Cancer Genet Cytogenet 112: 2-8.
1277. Ichikawa Y, Tsunoda H, Takano K, Oki
A, Yoshikawa H (2002). Microsatellite
instability and immunohistochemical
analysis of MLH1 and MSH2 in normal
endometrium, endometrial hyperplasia and
endometrial cancer from a hereditary nonpolyposis
colorectal cancer patient. Jpn J
Clin Oncol 32: 110-112.
1278. Ichinohasama R, Teshima S, Kishi K,
Mukai K, Tsunematsu R, Ishii-Ohba H,
Shimosato Y (1989). Leydig cell tumor of the
ovary associated with endometrial carcinoma
and containing 17 beta-hydroxysteroid
dehydrogenase. Int J Gynecol
Pathol 8: 64-71.
1279. Iczkowski KA, Han AC, Edelson MI,
Rosenblum NG (2000). Primary, localized
vulvar B-cell lymphoma expressing CD44
variant 6 but not cadherins. A case report.
J Reprod Med 45: 853-856.
1280. Idvall I, Andersson C, Fallenius G,
Ingvar C, Ringberg A, Strand C, Akerman
M, Ferno M (2001). Histopathological and
cell biological factors of ductal carcinoma
in situ before and after the introduction of
mammographic screening. Acta Oncol 40:
653-659.
1280a. Ihara N, Togashi K, Todo G, Nakai A,
Kojima N, Ishigaki T, Suginami N, Kinoshita
M, Shintaku M (1999). Sclerosing stromal
tumor of the ovary: MRI. J Comput Assist
Tomogr 23: 555-557.
1281. Ihekwaba FN (1994). Breast cancer in
men in black Africa: a report of 73 cases. J
R Coll Surg Edinb 39: 344-347.
1282. Imachi M, Tsukamoto N, Amagase H,
Shigematsu T, Amada S, Nakano H (1993).
Metastatic adenocarcinoma to the uterine
cervix from gastric cancer. A clinicopathologic
analysis of 16 cases. Cancer 71: 3472-
3477.
1283. Imachi M, Tsukamoto N, Shigematsu
T, Nakano H (1992). Cytologic diagnosis of
primary adenocarcinoma of Bartholin's
gland. A case report. Acta Cytol 36: 167-
170.
1284. Imachi M, Tsukamoto N, Shigematsu
T, Watanabe T, Uehira K, Amada S, Umezu
T, Nakano H (1992). Malignant mixed
Mullerian tumor of the fallopian tube:
report of two cases and review of literature.
Gynecol Oncol 47: 114-124.
1285. Imachi M, Tsukamoto N, Shimamoto
T, Hirakawa T, Uehira K, Nakano H (1991).
Clear cell carcinoma of the ovary: a clinicopathological
analysis of 34 cases. Int J
Gynecol Cancer 1: 113-119.
1286. Imai H, Kitamura H, Nananura T,
Watanabe M, Koyama T, Kitamura H
(1999). Mullerian carcinofibroma of the
uterus. A case report. Acta Cytol 43: 667-
674.
1287. Inaji H, Koyama H (1991). [Tumor
markers. Personal experience--screening
of breast cancer by determining CEA in
nipple discharge]. Gan To Kagaku Ryoho
18: 313-317.
1288. Innes KE, Byers TE (1999).
Preeclampsia and breast cancer risk.
Epidemiology 10: 722-732.
1289. Inoue H, Kikuchi Y, Hori T, Nabuchi K,
Kobayashi M, Nagata I (1995). An ovarian
tumor of probable Wolffian origin with hormonal
function. Gynecol Oncol 59: 304-308.
1290. Inoue T, Nabeshima K, Shimao Y,
Akiyama Y, Ohtsuka T, Koono M (2001).
Tubal ectopic pregnancy associated with
an adenomatoid tumor. Pathol Int 51: 211-
214.
1291. Inskip HM, Kinlen LJ, Taylor AM,
Woods CG, Arlett CF (1999). Risk of breast
cancer and other cancers in heterozygotes
for ataxia-telangiectasia. Br J
Cancer 79: 1304-1307.
1292. International Agency for Research
on Cancer (2002). IARC Handbooks of
Cancer Prevention Vol. 6: Weight Control
and Physical Activity. IARC Press: Lyon.
1293. International Agency for Research
on Cancer (1995). IARC Monographs on the
Evaluation of the Carcinogenic Risks to
Humans. Volume 64: Human papillomaviruses.
IARC Press: Lyon.
1294. International Agency for Research
on Cancer (1999). Hormonal contraceptives,
progestogens only. In: IARC
Monographs on the Evaluation of
Carcinogenic Risks to Humans Vol. 72
Hormonal Contraception and Post-
Menopausal Hormonal Therapy. I A R C
Press: Lyon , pp. 339-397.
1295. International Agency for Research
on Cancer (1999). IARC Monograph on the
Evaluation of Carcinogenic Risk to
Humans. Volume 72: Hormonal contraception
and post menopausal Hormonal
Therapy. IARC Press: Lyon.
1296. International Agency for Research
on Cancer (1999). Oral contraceptives,
combined. In: IARC Monographs on the
Evaluation of Carcinogenic Risks to
Humans Vol. 72 Hormonal Contraception
and Post-Menopausal Hormonal Therapy.
IARC Press: Lyon, pp. 49-338.
1297. International Agency for Research
on Cancer (1999). Post-menopausal
oestrogen-progestogen therapy. In: IARC
Monographs on the Evaluation of
Carcinogenic Risks to Humans Vol. 72
Hormonal Contraception and Post-
Menopausal Hormonal Therapy. I A R C
Press: Lyon, pp. 531-628.
1298. International Agency for Research
on Cancer (1999). Post-menopausal
oestrogen therapy. In: IARC Monographs
on the Evaluation of Carcinogenic Risks to
Humans Vol. 72 Hormonal Contraception
and Post-Menopausal Hormonal Therapy.
IARC Press: Lyon, pp. 399-530.
1299. International Cowden's Syndrome
Consortium, Operational Criteria for the
Diagnosis of CS, Daly M (1999). NCCN
practice guidelines: Genetics/familial highrisk
cancer screening. Oncology 13: 161-
186.
1300 . International Federation of
Gynecology and Obstretrics (1995).
Modifications in the Staging for Stage I
Vulvar and Stage I Cervical Cancer.
Reports of the FIGO Committee on
Gynaecologic Oncology. Int J Gynaecol
Obstet 50: 215-216.
1301. Iqbal M, Davies MP, Shoker BS,
Jarvis C, Sibson DR, Sloane JP (2001).
Subgroups of non-atypical hyperplasia of
breast defined by proliferation of oestrogen
receptor-positive cells. J Pathol 193:
333-338.
1302. Iraniha S, Shen V, Kruppe CN,
Downey EC (1999). Uterine cervical
extrarenal Wilms tumor managed without
hysterectomy. J Pediatr Hematol Oncol 21:
548-550.
1303. Isaac MA, Vijayalakshmi S, Madhu
CS, Bosincu L, Nogales FF (2000). Pure cystic
nephroblastoma of the ovary with a
review of extrarenal Wilms' tumors. Hum
Pathol 31: 761-764.
1304. Isaacs C, Stearns V, Hayes DF (2001).
New prognostic factors for breast cancer
recurrence. Semin Oncol 28: 53-67.
1305. Isaacson PG, Spencer J (1987).
Malignant lymphoma of mucosa-associated
lymphoid tissue. Histopathology 11: 445-
462.
1306 . Ishikura H, Kojo T, Ichimura H,
Yoshiki T (1998). Desmoplastic malignant
melanoma of the uterine cervix: a rare primary
malignancy in the uterus mimicking a
sarcoma. Histopathology 33: 93-94.
1307. Ishikura H, Scully RE (1987). Hepatoid
carcinoma of the ovary. A newly described
tumor. Cancer 60: 2775-2784.
1 3 0 8 . Ismail SM, Walker SM (1990).
Bilateral virilizing sclerosing stromal
tumours of the ovary in a pregnant woman
with Gorlin's syndrome: implications for
pathogenesis of ovarian stromal neoplasms.
Histopathology 17: 159-163.
1309. Ito K, Watanabe K, Nasim S, Sasano
H, Sato S, Yajima A, Silverberg SG, Garrett
CT (1994). Prognostic significance of p53
overexpression in endometrial cancer.
Cancer Res 54: 4667-4670.
1310. Ito T, Saga S, Nagayoshi S, Imai M,
Aoyama A, Yokoi T, Hoshino M (1986).
Class distribution of immunoglobulin-containing
plasma cells in the stroma of
medullary carcinoma of breast. B r e a s t
Cancer Res Treat 7: 97-103.
1311. Itoh T, Mochizuki M, Kumazaki S,
Ishihara T, Fukayama M (1997). Cystic pulmonary
metastases of endometrial stromal
sarcoma of the uterus, mimicking lymphangiomyomatosis:
a case report with
immunohistochemistry of HMB45. Pathol
Int 47: 725-729.
1312. Iversen T, Tretli S (1998). Intraepithelial
and invasive squamous cell neoplasia
of the vulva: trends in incidence, recurrence,
and survival rate in Norway. Obstet
Gynecol 91: 969-972.
1313. Iversen UM (1996). Two cases of
benign vaginal rhabdomyoma. Case
reports. APMIS 104: 575-578.
1314. Iwasaka T, Yokoyama M, Ohuchida
M, Matsuo N, Hara K, Fukuyama K,
Hachisuga T, Fukuda K, Sugimori H (1992).
Detection of human papillomavirus
genome and analysis of expression of c-
myc and Ha-ras oncogenes in invasive
cervical carcinomas. Gynecol Oncol 46:
298-303.
1315. Jack MT, Woo RA, Hirao A, Cheung
A, Mak TW, Lee PW (2002). Chk2 is dispensable
for p53-mediated G1 arrest but is
required for a latent p53-mediated apoptotic
response. Proc Natl Acad Sci USA .
99:9825-9829.
1316. Jackson-York GL, Ramzy I (1992).
Synchronous papillary mucinous adenocarcinoma
of the endocervix and fallopian
tubes. Int J Gynecol Pathol 11: 63-67.
1317. Jacobs AJ, Newland JR, Green RK
(1982). Pure choriocarcinoma of the ovary.
Obstet Gynecol Surv 37: 603-609.
1318. Jacobs DM, Sandles LG, Leboit PE
(1986). Sebaceous carcinoma arising from
Bowen's disease of the vulva. A r c h
Dermatol 122: 1191-1193.
1319. Jacobs PA, Szulman AE, Funkhouser
J, Matsuura JS, Wilson CC (1982). Human
triploidy: relationship between parental
origin of the additional haploid complement
and development of partial hydatidiform
mole. Ann Hum Genet 46: 223-231.
1320. Jacobs TW, Byrne C, Colditz G,
Connolly JL, Schnitt SJ (1999). Radial scars
in benign breast-biopsy specimens and the
risk of breast cancer. N Engl J Med 340:
430-436.
1321. Jacobsen GK, Braendstrup O,
Talerman A (1991). Bilateral mixed germ
cell sex-cord stroma tumour in a young
adult woman. Case report. APMIS Suppl
23: 132-137.
1321a. Jacobsen O (1946). Heredity and
Breast Cancer. London.
1322. Jacoby AF, Fuller AF Jr., Thor AD,
Muntz HG (1993). Primary leiomyosarcoma
of the fallopian tube. Gynecol Oncol 51:
404-407.
392 References